Fosun Pharma shares tumble more than 5% as Hong Kong suspends BioNTech Covid vaccinations

cnbc2021-03-24

KEY POINTS Fosun Pharma, BioNTech’s partner in the development and distribution of the Comirnaty Covid-19 vaccine in greater China, notified the Hong Kong and Macao of a packaging flaw in batch ...

Source Link
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Leave a comment
28